• 35 - A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

  • Aug 5 2024
  • Length: 25 mins
  • Podcast

35 - A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

  • Summary

  • Discussão do artigo: "A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia" de Metheny L Blood Adv. 2024 Mar 26;8(6):1384-1391

    Apresentado por: Dra. Thais Araujo

    Discussão por: Dr. Rafael Faust, Dra. Camila Ferreira, Dr. Pedro Arruda e Dr. Vinicius Molla

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 35 - A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.